Clinical Trial Update: Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality

View source ↗

Summary

This trial update reports on PET/CT imaging protocol optimization using optimized F18-FDG dosing to minimize radiation exposure while improving image quality.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colon Cancer
• Follicular Lymphoma
• Hodgkin Lymphoma
• Lung Cancer
• Lymph Node Metastasis
• Melanoma of the Skin
• Small Intestine Cancer

Snippet

Sponsor: Hospital Sao Rafael | Conditions: Malignant Neoplasm of Breast, Hodgkin Disease | Status: COMPLETED